ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first.
Time
7,037 announcements
Orkla India FY26 showed resilience with revenue growth despite deflation and geopolitical friction in GCC markets. Management is focusing on structural distribution changes and digital commerce to offset Kerala stagnation.
Hindware Home Innovation reported FY26 consolidated revenue of ₹2,193 crore with EBITDA of ₹198 crore. Management focuses on premiumization and a composite scheme of arrangement to unlock stakeholder value.
Speb Adhesives reported steady revenue growth but faces margin pressure from volatile crude-linked raw material costs. Management is aggressively pivoting from a family-run model to a professionalized, pan-India retail brand.
Banswara Syntex reported FY26 total income of ₹1,369.7 Cr (+4.8% YoY) and EBITDA of ₹143.6 Cr (+22.5% YoY), driven by growth in Fabric and Garment divisions.
Zee FY26 revenue at ₹80,989Mn (-2% YoY) with Adj. EBITDA margin of 9.3%. Pivot towards digital (ZEE5) delivering positive Adj. EBITDA.
Nurture Well Industries reported FY26 revenue of ₹1,026 Cr with a PAT of ₹100 Cr, driven by biscuit/bakery expansion and strategic acquisitions.
Yash Highvoltage reported record FY26 results with 57% revenue growth and 75% PAT growth. Management is focused on commissioning a new greenfield facility for resin-impregnated (RIP) bushings to drive localization and exports.
MapmyIndia Q4FY26 showed strong recovery with Revenue up 54.8% QoQ. FY26 revenue hit ₹474.1 Cr with focus on AI-based location solutions.
Hariom Pipe reports steady growth in Q3 FY26, driven by value-added products, though EBITDA per ton faced slight pressure from volatile raw material prices and finished goods price corrections.
Exicom turned consolidated EBITDA positive for the first time since acquiring Tritium, driven by scaling EV charger exports and improved product mix in critical power.
Texmaco reported Q4 FY26 revenue of ₹1,167cr (down 13.3% YoY) and PAT of ₹58cr. Management unveiled 'Texmaco 2.0' focusing on 2x revenue growth and mid-teen EBITDA margins by 2030.
Asian Energy (AESL) delivered record FY26 consolidated revenue of ₹791.1cr, up 70.1% YoY, driven by Kuiper acquisition and integrated service contracts. The company is transitioning toward a high-margin, asset-light upstream platform.
Deccan Gold is transitioning from exploration to production, recording its first profits via associate Geo Mysore. Management remains highly optimistic despite historical delays and a recurring need for external funding to operationalize projects.
Karnataka Bank reported strong Q4FY26 results with PAT at ₹408.19 Cr (up 40% QoQ). The Bank focuses on balance sheet consolidation and asset quality improvement under its transformation journey.
RITES Ltd reported Q4FY26 consolidated revenue growth of 27.7% YoY with 22.4% EBITDA margins. Management highlights highest-ever order book of ₹9416 crore and consistent export traction.
Mankind Pharma reported ₹14,278 Cr FY26 revenue, focusing on increasing chronic share (39.9% in Q4) and super-specialty expansion via BSV acquisition.
PTC India delivered robust trading volume growth of 12% in FY26, reaching 92.80 BUs. Total comprehensive income for the year stood at ₹398.28 Cr, with a dividend declaration of ₹8.50 per share.
Orient Bell delivered sequential revenue growth and strong EBITDA expansion despite volatile gas prices and industry-wide supply disruptions.
R K SWAMY reports 15% annual revenue growth for FY26 with strong margin expansion. Strategy focuses on integrated marketing services and digital content production at scale.
Timken India delivered a resilient performance in Q4 FY26, crossing the ₹1,000 crore quarterly revenue milestone for the first time despite rising raw material inflation.
Spunweb (SNL) delivered strong FY26 results with 22.2% revenue growth and 54.7% PAT growth, driven by hygiene sector demand and strategic capacity expansion in Gujarat.
Nephrocare Health Services (NephroPlus) reported strong FY26 performance with revenue reaching ₹998.8 Cr, driven by international expansion and increased treatment volumes.
Anthem Biosciences achieved record Q4FY26 revenue of ₹6,109 Mn. The company delivered 15.2% FY26 revenue growth with strong EBITDA margins of 43.4% driven by its CRDMO segment.
Metropolis Healthcare reports strong FY26 performance with 23.6% YoY revenue growth and 24.4% EBITDA margin. Strategy focuses on network productivity, genomics, and expanding 'mini hubs' for pathology and basic radiology.
Zydus delivered a record-breaking FY26 with 17% revenue growth and peak EBITDA margins of 31.2%, significantly exceeding internal expectations.
Shree Pushkar delivered steady growth in FY26, but management is now deferring major expansions (Unit 5 & 6) due to extreme raw material price volatility and global supply chain disruptions.
JTEKT India reported 11% FY26 revenue growth to ₹26,656 Mn, slightly outperforming 9% industry growth. EBITDA margins dipped 10 bps to 7.5% due to mix changes and higher costs.
Viyash Q4 FY26 revenue reached ₹9,200 Mn with 21.7% EBITDA margins. Management highlights successful integration and a deleveraged balance sheet.
Zim Laboratories reported FY26 revenue of ₹3,744 Mn with 11.1% EBITDA margin. Strategy shifts towards innovative products (NIP/OTF) despite regulatory headwinds and geopolitical logistics challenges.
GNFC reports strong FY26 profitability driven by chemical realizations and exceptional items, despite urea segment headwinds.